What is the use and dosage of Triamterene in treating edema and hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triamterene for Edema and Hypertension

Triamterene is a potassium-sparing diuretic indicated for treating edema associated with congestive heart failure, cirrhosis, nephrotic syndrome, and hypertension, with a standard adult dosage of 100 mg twice daily after meals, not exceeding 300 mg daily. 1

Mechanism and Clinical Use

Triamterene works by inhibiting the epithelial sodium channel (ENaC) in the distal convoluted tubule and collecting duct of the kidney, which:

  • Reduces sodium reabsorption and potassium secretion
  • Produces mild diuresis and natriuresis
  • Conserves potassium, preventing hypokalemia

Dosage Guidelines

Adults:

  • Initial dose: 100 mg twice daily after meals 1
  • Maximum daily dose: 300 mg 1
  • Maintenance dose: Titrated based on clinical response

Children:

  • Initial dose: 1-2 mg/kg/day 2
  • Maximum dose: 3-4 mg/kg/day up to 300 mg/day 2
  • Dosing frequency: Twice daily (BID) 2

Clinical Indications

Triamterene is indicated for:

  1. Edema associated with:

    • Congestive heart failure
    • Cirrhosis of the liver
    • Nephrotic syndrome
    • Steroid-induced edema
    • Idiopathic edema
    • Secondary hyperaldosteronism 1
  2. Hypertension:

    • As monotherapy (though less common)
    • In combination with other antihypertensives, particularly thiazide diuretics 3

Combination Therapy

Triamterene is often used in combination therapy:

  1. With thiazide diuretics:

    • Enhances blood pressure-lowering effect (3-4 mmHg additional reduction) 3
    • Counteracts thiazide-induced hypokalemia 4
    • Creates synergistic diuretic effect 5
  2. For resistant edema:

    • Can be combined with loop diuretics for enhanced effect 2
    • Particularly useful in patients refractory to other diuretics 5

Monitoring and Precautions

Required Monitoring:

  • Serum electrolytes (particularly potassium)
  • Renal function
  • Blood pressure
  • Clinical signs of fluid retention

Precautions:

  1. Hyperkalemia risk:

    • Avoid concurrent use with other potassium-sparing diuretics 2
    • Discontinue all potassium supplements when starting triamterene 1
    • Use with caution when combined with ACE inhibitors or ARBs 2
  2. Renal considerations:

    • Risk of acute kidney injury, especially with NSAIDs 6
    • Potential for nephrolithiasis and interstitial nephritis 6
    • Use with caution in patients with renal impairment
  3. Pregnancy considerations:

    • Not recommended for routine use in healthy pregnant women
    • May be appropriate for pathological edema in pregnancy 1

Clinical Pearls

  1. Potassium management:

    • When adding triamterene to existing diuretic therapy, discontinue all potassium supplementation 1
    • Monitor serum potassium closely, especially when combined with ACE inhibitors or ARBs
  2. Blood pressure effect:

    • Beyond its potassium-sparing properties, triamterene independently enhances blood pressure reduction when combined with hydrochlorothiazide 3
  3. Resistant edema:

    • Particularly valuable in long-term management of chronic edema resistant to other diuretics 5
    • Effective in patients with secondary hyperaldosteronism 1
  4. Drug interactions:

    • Avoid concurrent use with NSAIDs due to risk of acute kidney injury 6
    • Use caution when combining with ACE inhibitors or ARBs due to hyperkalemia risk 2

Triamterene remains a valuable option in managing edema and hypertension, particularly when potassium conservation is desired or when enhanced diuretic effect is needed in combination therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

TREATMENT OF CONGESTIVE HEART FAILURE WITH TRIAMTERENE.

Canadian Medical Association journal, 1965

Research

Triamterene and the kidney.

Nephron, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.